EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression

Navy C Coggins, Hanson A Chokr, Tricia A Meyer, Mihir Patel, Sahar Shekoohi, Alan D Kaye

Current Pain and Headache Reports · 2026-12 · 30 (1)

DOI: 10.1007/s11916-026-01475-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Pain and Headache Reports, online erschienen am 21.04.2026. Verfasst von Navy C Coggins und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, 71103, USA. Hauptthemen laut MEDLINE: Ketamine, Analgesics, Pain Management, Depression. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: Ketamine was originally developed as a dissociative anesthetic and has remained a valuable agent in anesthesia related to its ability to preserve airway reflexes and relative hemodynamic stability. Over time, its clinical applications have expanded beyond procedural sedation to include roles in pain management and psychiatry. In pain medicine, the therapeutic rationale is primarily grounded in its noncompetitive antagonism of the N-methyl-D-aspartate (NMDA) receptor and modulation of central sensitization, a key mechanism underlying refractory neuropathic and centralized pain states. RECENT FINDINGS: Evidence from preclinical studies and randomized clinical trials suggests that intravenous ketamine may provide short-term analgesic benefit in the treatment of resistant neuropathic pain, phantom limb pain, and complex regional pain syndrome. Low-dose perioperative administration has demonstrated opioid-sparing effects as part of multimodal analgesia strategies. However, heterogeneity in dosing protocols, variability in duration of response, and limited long-term data restrict definitive recommendations. In psychiatry, ketamine and its S-enantiomer, esketamine, have demonstrated rapid antidepressant effects in patients with major depressive disorder and treatment-resistant depression, further highlighting its evolving therapeutic scope. Despite these promising applications, the use of ketamine requires careful patient selection and monitoring related to dissociative effects, cardiovascular changes, and potential for misuse. This narrative review synthesizes current evidence regarding ketamine’s mechanistic basis and clinical utility across anesthesia, pain management, and psychiatry, with particular emphasis on its role in chronic and perioperative pain. Continued research is needed to clarify optimal dosing strategies, durability of response, and long-term safety across diverse patient populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineAnalgesicsPain ManagementDepressionHumansAntidepressive Agents

Stichwörter der Autor:innen

Central sensitizationKetamineMultimodal analgesiaNMDA receptor antagonismNeuropathic painOpioid-sparingPerioperative analgesiaTreatment-resistant depression

Substanzen

KetamineAnalgesicsAntidepressive Agents

Autor:innen und Institutionen

  • School of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, 71103, USA.
  • Texas A&M School of Medicine, 6605 Springwood Ct., Temple, TX, 76502, USA.
  • Department of Anesthesiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, 71103, USA.
  • Department of Anesthesiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, 71103, USA. sahar.shekoohi@lsuhs.edu.

Zitieren

APA

Coggins, N. C., Chokr, H. A., Meyer, T. A., Patel, M., Shekoohi, S., & Kaye, A. D. (2026). Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression. Current Pain and Headache Reports, 30(1). https://doi.org/10.1007/s11916-026-01475-7

Vancouver

Coggins NC, Chokr HA, Meyer TA, Patel M, Shekoohi S, Kaye AD. Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression. Current Pain and Headache Reports. 2026;30(1). doi:10.1007/s11916-026-01475-7

BibTeX
@article{Coggins2026,
  author = {Coggins, Navy C and Chokr, Hanson A and Meyer, Tricia A and Patel, Mihir and Shekoohi, Sahar and Kaye, Alan D},
  title = {Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression},
  journal = {Current Pain and Headache Reports},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.1007/s11916-026-01475-7}
}
Kostenlos starten →